The global market for Non-Human Primate (NHP) preclinical studies conducted by Contract Research Organizations (CROs) is experiencing significant growth, fueled by advancements in drug development and a heightened focus on infectious diseases. According to Polaris Market Research, the market was valued at USD 39,546.55 Thousand in 2022 and is projected to reach $1.08,553.86 Thousands By 2032,...